Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

TRML Tourmaline Bio Inc

13,77

0,25 (1,85%)

31 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Form 3 - Initial statement of beneficial ownership of securities

Tourmaline Bio (NASDAQ:TRML)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Click Here for more Tourmaline Bio Charts.

Tourmaline Bio (NASDAQ:TRML)
Historical Stock Chart
Von Jun 2023 bis Jun 2024

Click Here for more Tourmaline Bio Charts.

News Tourmaline Bio Inc

Tourmaline Bio to Present at the Jefferies Global Healthcare Conference
Donnerstag 23 Mai 2024 (1 Woche vor) • GlobeNewswire Inc.

Tourmaline Bio Initiates Clinical Development of TOUR006 for Cardiovascular Diseases with First Patient Dosed in Phase 2 TRANQUILITY Trial
Donnerstag 16 Mai 2024 (2 Wochen vor) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Montag 13 Mai 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 13 Mai 2024 (3 Wochen vor) • Edgar (US Regulatory)

Tourmaline Bio Reports First Quarter 2024 Financial Results and Recent Business Highlights
Montag 13 Mai 2024 (3 Wochen vor) • GlobeNewswire Inc.

Avalo Therapeutics Appoints Biotech Leaders to Board of Directors
Dienstag 2 April 2024 (2 Monate vor) • GlobeNewswire Inc.

Tourmaline Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
Dienstag 19 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Tourmaline Bio to Present at Upcoming Investor Conferences
Dienstag 27 Februar 2024 (3 Monate vor) • GlobeNewswire Inc.

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Donnerstag 15 Februar 2024 (4 Monate vor) • Edgar (US Regulatory)

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Donnerstag 15 Februar 2024 (4 Monate vor) • Edgar (US Regulatory)

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Freitag 9 Februar 2024 (4 Monate vor) • Edgar (US Regulatory)

Tourmaline Bio to Present at the Guggenheim Healthcare Talks | 6th Annual Biotechnology Conference
Donnerstag 1 Februar 2024 (4 Monate vor) • GlobeNewswire Inc.

Weitere Tourmaline Bio Inc News-Artikel

Gold vs US Dollar

Euro vs US Dollar

Health Care Select Sector

Deutsche Telekom

Invesco QQQ Trust Series 1

Financial Select Sector

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen